Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Nurix therapeutics, inc. symbols : SNYNF save search
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: 18.35%
H: 1.98%
C: -5.88%
first update therapeutics financial results
Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
Published: 2024-04-09 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.38%
H: 0.95%
C: 0.83%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
protein collaboration extension therapeutics sanofi
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update
Published: 2024-02-15 (Crawled : 21:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.59%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: -6.09%
H: 9.95%
C: 6.7%
year update therapeutics financial results
Nurix Therapeutics Outlines 2024 Strategic Priorities with Advancement of Targeted Protein Modulation Pipeline in Cancer and Autoimmune Diseases
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 2.07%
H: 0.48%
C: 0.48%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: -1.01%
H: 2.76%
C: 1.94%
cancer pipeline protein therapeutics
Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
Published: 2023-10-12 (Crawled : 20:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: 2.57%
H: 1.56%
C: -0.31%
update therapeutics financial results
Nurix Therapeutics Reports Second Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
Published: 2023-07-13 (Crawled : 20:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: 7.54%
H: 6.83%
C: -9.96%
update therapeutics financial results
Nurix Therapeutics Reports First Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
Published: 2023-04-13 (Crawled : 22:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: 1.78%
H: 11.56%
C: 10.47%
update therapeutics financial results
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides a Corporate Update
Published: 2023-02-09 (Crawled : 22:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.39%
H: 0.0%
C: 0.0%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: -1.87%
H: 6.9%
C: 5.72%
year therapeutics financial update results
Nurix Therapeutics Advances Promising Targeted Protein Modulation Pipeline and Outlines 2023 Strategic Priorities
Published: 2023-01-09 (Crawled : 14:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: -8.06%
therapeutics
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update
Published: 2022-07-07 (Crawled : 21:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: -1.19%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.38%
H: 0.64%
C: 0.24%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: -0.42%
H: 9.05%
C: 7.65%
therapeutics update results
Nurix Therapeutics Reports Fiscal First Quarter 2022 Financial Results and Provides a Corporate Update
Published: 2022-04-07 (Crawled : 21:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 4.21%
H: 0.0%
C: -0.61%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.74%
H: 0.0%
C: 0.0%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: -0.36%
H: 3.85%
C: -3.7%
therapeutics results
Kim Trahan
Published: 2021-11-15 (Crawled : 20:00) - nurixtx.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: -1.34%
H: 0.92%
C: -1.51%
BioSpace Movers & Shakers, Oct. 22
Published: 2021-10-22 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: -0.41%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.09%
H: 1.28%
C: 1.16%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.37%
H: 1.06%
C: 0.96%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
OCUL | News | $4.645 -7.1% -7.64% 3.9M
|
Health Technology
|
| O: -27.15%
H: 0.89%
C: -12.42%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: 0.43%
H: 0.11%
C: -0.81%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
space spac
Nurix Therapeutics Reports Third Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
Published: 2021-10-14 (Crawled : 21:00) - globenewswire.com
VRTX | $400.66 -1.05% -1.06% 810K
|
Health Technology
|
| O: 0.32%
H: 0.37%
C: -0.39%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.24%
H: 2.56%
C: 1.25%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.35%
H: 1.12%
C: 0.89%
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: 0.91%
H: 1.23%
C: 0.24%
financial results results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.